Organ-on-Chip Market Overview, Share, Growth Drivers and Forecast Report 2023

Global organ-on-chip market size is forecasted to reach $163.1 million by 2025. The growth in the market will be led by the rising need for effective drug discovery and development, increasing demand for alternatives for animal models in research, increasing drug repurposing approaches, and government grants and funds for research.

Download report sample at: https://www.psmarketresearch.com/market-analysis/organ-on-chip-market/report-sample

The organ-on-chip market has been categorized into product and services, on the basis of offering by the market players. The products are expected to register faster growth in demand, registering a CAGR of 43.8% during the forecast period, due to the advancement in research leading to arrangement of newer organs cells on chips.

In terms of type, the organ-on-chip market has been categorized as liver-on-chip, lung-on-chip, kidney-on-chip, heart-on-chip, intestine-on-chip, brain-on-chip, and others. Among these, liver-on-chip held the largest share in the global organ-on-chip market, in 2017. The increasing prevalence of chronic liver diseases, and advancement in research for its therapeutic intervention are the key factors for the largest share of the category.

Browse report at: https://www.psmarketresearch.com/market-analysis/organ-on-chip-market

Organ-on-chip products find application in toxicology research, physiological model development, and drug discovery. The application of organ-on-chip for drug discovery is projected to witness fastest growth in demand, registering CAGR of 47.7% during the forecast period. On the basis of end user, the adoption of organ-on-chip by pharmaceutical and biotechnology companies is higher as compared to academic & research institutes, and other end users since a majority of grants and investments for research and development are received by these companies.

Furthermore, in February 2017, InSphero AG introduced the GravityTRAP 384 Microtissue Platform at the Society for Laboratory Automation and Screening (SLAS) 2017 Conference. The GravityTRAP 384 platform features distinct microtissue culture and media chambers separated by a tapered SureXchange pipetting ledge, and a continuous flat-bottomed glass base plate combined with a black-walled body, ensuring superior confocal and high content imaging optics while reducing fluorescent cross-talk between wells.

Some of the other key players operating in the organ-on-chip industry include Emulate Inc., Mimetas B.V., TissUse GmbH, Kirkstall Ltd., CN Bio Innovations Ltd, Ascendance Biotechnology, Inc., Nortis, Inc., and Organovo Holdings, Inc.

GLOBAL ORGAN-ON-CHIP MARKET SEGMENTATION

By Offering

• Services
• Products

By Type

• Liver-on-Chip
• Lung-on-Chip
• Kidney-on-Chip
• Heart-on-Chip
• Intestine-on-Chip
• Brain-on-Chip
• Others

By Application

• Toxicology Research
• Physiological Model Development
• Drug Discovery

By End User

• Pharmaceutical & Biotechnology Companies
• Academic Research Institutes
• Others

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact: P&S Intelligence Toll-free: +1-888-778-7886 (USA/Canada) International: +1-347-960-6455 Email: enquiry@psmarketresearch.com Web: https://www.psmarketresearch.com